• Scalable synthesis of (Mo 2/3 Y 1/3 ) 2 AlC i- MAX phase via self-propagating high-temperature synthesis (SHS) in under one minute without external energy input. • Product yield increased to 73.6% through the use of AlY 2.3 master alloy. • Study of reaction kinetics shows how the use of the master alloy increases the phase purity. • MXene yield approximately doubled compared to conventional synthesis methods. For MXenes to be viable in commercial and industrial applications, their production must rely on processes that are energy-efficient, environmentally sustainable, and scalable. A critical factor influencing this viability is the synthesis route of the parent MAX phase. In this study, we report a novel and rapid approach for synthesizing a chemically ordered MAX phase ( i- MAX), specifically the in-plane ordered (Mo 2/3 Y 1/3 ) 2 AlC, using self-propagating high-temperature synthesis (SHS) completed in one minute. The target MAX phase yield was estimated using Rietveld refinement to be 73.6% with the main impurity phases identified as Mo 3 Al 2 C and YF 3 . Thermodynamic calculations combined with experimental characterizations indicate that the use of an aluminum–yttrium master alloy played a pivotal role in achieving high synthesis yield by facilitating a sequence of intermediate phase transformations that enhance reaction kinetics and i- MAX formation. This method involves the utilization of Poly(tetrafluoroethylene)—(C 2 F 4 ) n as a promoter, which enables the formation of volatile fluorides or fluorine-containing intermediates, making the reaction self-sustaining. Etching and delamination of the SHS-produced i- MAX phase yielded a vacancy-ordered MXene with the formula Mo 4/3 CT x , with a yield value twice that obtained using the conventional MAX-phase parent material preparation route. This work demonstrates the method’s effectiveness in achieving rapid, straightforward, and energy-efficient synthesis of a diverse range of MAX and i- MAX phases, thereby paving the way for scalable and efficient MXene production.
No takes yet. Share an insight, caveat, or question.
Shamshirgar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: